Australian Clinical Labs Ltd has released a press release.
1H FY22 Updated Profit Guidance
Filed with ASX ·
6ix hasn’t read this filing yet.
Australian Clinical Labs Ltd on 6ix
Story so far
Earlier from Australian Clinical Labs
- Preliminary Final Report
- FY21 financial results investor presentation
- Upgraded FY21 earnings guidance by 10 to 15%
Later from Australian Clinical Labs
- 2021 AGM addresses and 1H22 trading update
- Acquisition of Medlab Pathology by ACL
- Medlab Pathology - Investor Presentation
- Completion of Medlab Acquisition
- Upgrade to 1H FY22 Pro Forma Expectations
Follow Australian Clinical Labs into a list and get an email when it puts out news.
Follow Australian Clinical Labs